When Circa was founded in 2006, the company’s aim was to convert non-food cellulose into high-performance, renewable chemicals, at scale — extracting value from waste biomass and addressing a gap in the market for better, more sustainable materials.
As gender and diversity, as well as the body positivity movement, become more and more prevalent among young consumers, beauty companies are finding that they are going to have to re-define how products are advertised if they want to stay relevant.
Yiğitoğlu, the family-run Turkish chemical manufacturing, distribution and logistics services group that started commercial activities in 1956, has set out to expand its geographic footprint.
Dago Caceres, Global Strategy Manager for Pharma Solutions at IFF, talks about the new IFF and the strategy ahead for the pharmaceutical division in particular.
Analysis of the mergers & acquisitions activity in chemical distribution under the impression of the pandemic situation and how it might develop going forward.
In a nutshell, reaching sustainability has become a key aspect for chemical companies and adjacent businesses along the product chain with a high entry hurdle for everyone.
The International Society for Pharmaceutical Engineering (ISPE) announced the 2021 Facility of the Year Awards (FOYA) Category Winners—including two winners of Special Recognition Awards for Operational Agility: Covid-19 Impact.
Marcus Michel, CEO of ACG Engineering, analyzes market trends in pharmaceutical engineering and manufacturing.
Interview with Michael Postlethwaite, Senior Director, Sales & Business Development, European Territories, AmbioPharm
Interview with Christophe Couturier and Claudia Berrón, Avantor
Over the years, sustainability has evolved from an aspirational goal to an operational priority. Companies in every industry are being asked to incorporate more environmental stewardship into their operations and business practices.
Michael Reubold talked to Evonik’s Sanjeev Taneja about the role of catalysts in the company and their value to the industry and the society.
The global market for oligonucleotide therapeutics is expanding rapidly. Bachem, an innovation-driven company based in Bubendorf, Switzerland, has entered this competitive environment in 2019.
WeylChem’s Custom Manufacturing division has a strong record of accomplishments operating in markets such as Pharma, Agro and Pigments.
BASF has created ZoomLab, a virtual formulation prediction and optimization tool, to help address the challenges of drug product development.
Sean Diver, president of DCAT speaks about the pharmaceutical industry’s role during the Covid-19 pandemic, trends in drug manufacturing, and key issues for the EU pharmaceutical industry.
The pharmaceutical industry is increasingly focused on the development of specialized drug products with new treatment modalities, including previously undruggable targets for oncology and other areas.
For biopharma leaders it is more critical than ever to secure the capabilities to contain, handle, develop and manufacture highly potent APIs.
Andrew Badrot, CEO of C2 Pharma and a close observer of pharma industry trends, analyzes the current situation and how this pandemic may kick of changes in the pharma market.
As a fully digital player in the chemical industry, CheMondis regularly offers webinars for buyers and suppliers.
Synthace’s multidisciplinary team of researchers and software engineers have developed the Antha software platform to lower the barriers for scientists to execute sophisticated experiments with automated laboratory equipment.
Designed for their performance and durability, synthetic plastics have become indispensable as “materials of every-day use”. However, their characteristic long life span and indiscriminate disposal have led to an acute problem of plastic pollution. In order to address this issue, the European Union is not only trying to adopt a circular system to reuse, repair and recycle plastics (circular economy) but it also aims to produce plastics out of renewable resources (biobased plastics).
Cellugy was founded two years ago by a diverse team of young academics and professionals from Spain, Indonesia, Albania, and Denmark. Working together at Aarhus University in Denmark, the idea of developing a material based on nanocellulose as an alternative to plastic barrier coatings arose and grew into a start-up and a first product. Co-founders Isabel Alvarez-Martos and Deby Fapyane talk about their motivation and vision.
The change in many chemical companies’ product portfolio away from commodities to customer-specific specialties is one of the current challenges facing the process industry.
The change in many chemical companies’ product portfolio away from commodities to customer-specific specialties is one of the current challenges facing the process industry.
The change in many chemical companies’ product portfolio away from commodities to customer-specific specialties is one of the current challenges facing the process industry.
The change in many chemical companies’ product portfolio away from commodities to customer-specific specialties is one of the current challenges facing the process industry.
The change in many chemical companies’ product portfolio away from commodities to customer-specific specialties is one of the current challenges facing the process industry.
The change in many chemical companies’ product portfolio away from commodities to customer-specific specialties is one of the current challenges facing the process industry.
The change in many chemical companies’ product portfolio away from commodities to customer-specific specialties is one of the current challenges facing the process industry.
The change in many chemical companies’ product portfolio away from commodities to customer-specific specialties is one of the current challenges facing the process industry.
